학술논문
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
Document Type
Article
Author
Schuster, Stephen J ; Tam, Constantine S; Borchmann, Peter; Worel, Nina; McGuirk, Joseph P; Holte, Harald; Waller, Edmund K; Jaglowski, Samantha; Bishop, Michael R; Damon, Lloyd E; Foley, Stephen Ronan; Westin, Jason R; Fleury, Isabelle; Ho, P Joy; Mielke, Stephan; Teshima, Takanori; Janakiram, Murali; Hsu, Jing-Mei; Izutsu, Koji; Kersten, Marie José; Ghosh, Monalisa; Wagner-Johnston, Nina; Kato, Koji; Corradini, Paolo; Martinez-Prieto, Marcela; Han, Xia; Tiwari, Ranjan; Salles, Gilles; Maziarz, Richard T
Source
In The Lancet Oncology October 2021 22(10):1403-1415
Subject
Language
ISSN
1470-2045